**New Fat Transfer Procedure Offers Alternative to Traditional Methods**
:max_bytes(150000):strip_icc():format(jpeg)/syringe-needle-022426-4bdbce0537fb46c69a40f58a000594b5.jpg)
A groundbreaking plastic surgery technique has emerged, enabling patients to receive fat transfers derived from cadavers. This innovative approach, named alloClae, was launched by Tiger Aesthetics in 2025 and marks a significant leap in aesthetic body procedures.
AlloClae, described as the “first structural adipose tissue designed for aesthetic body procedures,” offers a unique method of enhancing volume, cushioning, and support in targeted areas. The procedure utilises donor-derived tissue, which can be injected directly into patients without the prior need for liposuction—a practice traditionally employed to harvest a patient’s own fatty tissue.
Dr. Bob Basu, a plastic surgeon based in Houston and a proponent of this new technique, shared insights into the procedure. He explained that as individuals increasingly resort to GLP-1 medications for weight management, many may find themselves with insufficient personal fat reserves for conventional fat transfer. “Because it is donor-derived and ready to use, it allows surgeons to add volume in a controlled and targeted way,” Dr. Basu explained.
This precise nature of the alloClae procedure is particularly beneficial for patients who desire subtle enhancements. The technique allows for incremental contouring, ideal for individuals who may be slim or those seeking only modest changes in their appearance.
One of the key advantages of alloClae is that it can be performed under local anaesthesia, making it a viable option for patients looking to avoid the risks and recovery time associated with general anaesthesia. Dr. Basu noted, “Treatment is typically performed as an in-office procedure under local anaesthesia. The product is introduced beneath the skin through small access points, using either a needle or a small cannula depending on the treatment area.”
This minimally invasive procedure can significantly reduce recovery time, allowing patients to return to their daily routines more quickly than with traditional surgical methods. The process involves layering the donated tissue with precision, offering surgeons the ability to enhance contour and shape effectively.
The fat used in alloClae is sourced from cadaveric human adipose tissue and is obtained through a strictly regulated tissue donation process. This ensures that all donated materials meet rigorous health and safety standards; donors undergo thorough medical screening and testing before their tissues are processed. “Donation must be properly authorised, and donors must meet specific health and safety criteria,” Dr. Basu affirmed, underscoring the need for compliance to maintain safety in such procedures.
Despite its innovation, the alloClae procedure is not without limitations. As a new technique, the long-term effects remain largely unknown. Dr. Basu emphasised that while it’s designed for subtle volume enhancements and contour refinement, individuals seeking dramatic changes in body shape may be better suited to traditional fat transfer methods or surgical options.
Furthermore, not all patients may qualify for this treatment. Each case must be evaluated individually, taking into account factors such as overall health, specific goals, and individual anatomical considerations. “There are potential risks, and it is essential that patients engage in a thorough discussion with a board-certified plastic surgeon before proceeding,” Dr. Basu advised.
The introduction of alloClae presents an exciting development in the realm of plastic surgery, offering a fresh alternative for those looking to enhance their appearance without the need for more invasive procedures. As the popularity of aesthetic treatments continues to rise, innovations like the alloClae procedure underscore the evolving nature of cosmetic surgery, making aesthetic enhancements more accessible and tailored to individual patient needs.